Theralase Technologies Inc. V.TLT

TLT is working with FDA on BTD

[Donein25]

There more than 11,000 biotechnology companies worldwide. 6 have received Breakthrough Designation this year. Six!  So don't loose faith because of stock price manipulation, small PPs, seemingly endless stretches of silence from management and negative posters; You own stock in a company on the cusp of BTD. The FDA wants our technology to succeed and I believe some pharma is going to pay us a lot of $$ for this technology.

[Galaxym31]

Therapy is welcome . Thanks . Also all those humans who worry about being alone in the universe dont despair we have only been on the scene for a few cosmic seconds .

[ScienceFirst]

Donein25 ... Great post and great perspectives. __________   Donein25 - (8/29/2023 9:32:26 PM) TLT is working with FDA on BTD There more than 11,000 biotechnology companies worldwide. 6 have received Breakthrough Designation this year. Six!  So don't loose faith because of stock price manipulation, small PPs, seemingly endless stretches of silence from

[PrettyPennies]

  I thought this article oils be of interest, even though it it 4 years old. https://seekingalpha.com/article/4314267-real-value-of-breakthrough-therapy-designation?utm_source=pocket_reader

[PrettyPennies]

The Real Value Of A Breakthrough Therapy Designation Dec. 30, 2019 8:30 AM ETACAD, ALNY, BIIB, CPRX, HDV, MRKR, NBIX, NVO, PGNX, RHHBY, STML, THTX, CYDY, DCPH, EIGR, IOVA, NKTR, TH:CA30 Comments Theodore Zucconi 661 Followers   Summary

[Oilminerdeluxe]

At first glance, it looks like a solid update. Glad to see that BTD is within reach. Hopefully, no money woes after that. 

[Gooseybear]

I hope you're right Donein25.

[Lesalpes29]

Seems that we have a clear target date for BTD. They are working to get it before year end and AA will follow shortly in 2024. All good! GL

[socalbob]

Is there a clear target date for BTD?   After, unfortunately, and at this point, embarrassingly, being in this stock for over a decade, my reading of each release looks for the nuance in the language of statements released by this company. "Once the pre-BTD submission has been accepted by the FDA, the Company plans to compile a BTD submission for review by the FDA in support of the

[enriquesuave]

Clearly if data was not good enough, I believe the FDA would have stated so by now..  Probably it's the  FDA required format which needs to be completed for preBTD and BTD.  Adstiladrin approved a few months ago at 24% CR and 4 treatments with more side effects, we have 33% CR and less treatments and side effects,  hard to believe we shouldn't get BTD followed by AA